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Abstract Ribosome-inactivating proteins (RIPs) display ad-
enine polynucleotide glycosylase activity on di¡erent nucleic
acid substrates, which at the ribosomal level is responsible for
the arrest of protein synthesis. Some type 2 RIPs, namely ricin
and related proteins, are extremely toxic to mammalian cells
and animals whilst other type 2 RIPs (non-toxic type 2 RIPs)
display three to four logs less toxicity. We studied whether a
correlation exists between toxicity on cells and enzymatic activ-
ity on nucleic acids. All type 2 RIPs di¡er in their depurinating
activity on the di¡erent substrates with di¡erences of up to one
to two logs. The toxicity of type 2 RIPs is independent of their
enzymatic activity on nucleic acids or on ribosomes.
& 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Ribosome-inactivating proteins (RIPs) from plants are clas-
sically divided into two categories: type 1, single-chain pro-
teins with enzymatic activity, and type 2, consisting of an
enzymic A chain, similar to type 1 RIPs, linked to a B chain
with lectin properties [1]. More recently a type 3 was intro-
duced, including a single RIP from maize, in which the enzy-
mic chain has an additional peptide tail that must be removed
for the RIP to be active (review in [2]).
Type 2 RIPs, the ¢rst ones to be known, were considered to
be highly toxic because their B chain binds to galactosyl-ter-
minated receptors on the cell surface, thus allowing the entry
of the A chain into the cytoplasm where it exerts its enzymatic
activity on ribosomes, inhibiting cell protein synthesis with
IC50s in the nM range or below. Since early times it has
been known that enzymatic activity was not synonymous
with toxicity since Ricinus agglutinin (RCA 120) was scarcely
toxic to cells and animals although it shares an identical A
enzymatic subunit with the extremely toxic ricin [3], although
this observation was considered to be an exception to the rule.
Subsequently, however, a number of type 2 RIPs were iden-
ti¢ed, which have structural and enzymatic properties similar
to those of ricin and related toxins but, like RCA 120, are
much less toxic to cells and animals: this group of proteins
was named non-toxic type 2 RIPs (reviewed in [3,4]). The
reasons for this di¡erence are not completely understood.
The enzymatic activity of RIPs was o⁄cially de¢ned as an
rRNA N-glycosidase (rRNA N-glycohydrolase, EC 3.2.2.22),
after it was found that they remove an adenine residue from
rRNA [5]. Subsequently some RIPs were found which re-
moved more than one adenine per ribosome [6,7]. Further-
more, it was observed that all RIPs remove adenine not
only from RNA, but also from DNA and some of them
also from other adenosine-containing macromolecules [8,9],
and the name polynucleotide adenine glycosylase was pro-
posed for these proteins [10]. It is still not known whether
the depurinating activity on substrates other than ribosomes
has a role in the cytotoxic activity of RIPs, although preco-
cious alterations possibly not dependent on inhibition of
translation were observed in the nuclei of cells exposed to
ricin or Shiga toxin [11].
From the investigations reported above, performed mainly
with type 1 and with a few, toxic [8] and non-toxic [12], type 2
RIPs, it appeared that among RIPs there are di¡erences in the
enzymatic activity and in the speci¢city for substrates. The
present investigation was undertaken to compare the enzy-
matic activity of a number of toxic and non-toxic type 2
RIPs on various nucleic acid substrates.
2. Materials and methods
2.1. Materials
RIPs were puri¢ed as described in the respective references: abrin a
[13], cinnamomin [14], ebulin l [15], ebulin r1 and ebulin r2 [16], IRA
b and IRA r [17], modeccin [18], nigrin b [19], ricin and RCA 120 [20],
SNA I and SNLRP [21], mistletoe lectin I (viscumin) [22], volkensin
[23]. Lectins were reduced by incubation with 1% 2-mercaptoethanol
for 1 h at 37‡C. Rat liver ribosomes were prepared essentially as
described elsewhere [24] in RNase-free conditions. Their concentration
was determined by the A260 as described in [25], assuming that 12.5
absorbance units/ml was equivalent to 1 mg/ml and that 1 mg con-
tained 250 pmol of ribosomes. Ribosomes were stored in aliquots at
80‡C.
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Herring sperm DNA (hsDNA) obtained from Sigma was mechan-
ically sheared. Escherichia coli rRNA was from Boehringer Mannheim
(Mannheim, Germany). Chemicals, as far as possible RNase-free,
were as in previous work [9]. Water was ‘milli-Q’ grade (Millipore).
2.2. Enzymatic activities
Cell-free protein synthesis was assayed with a rabbit reticulocyte
lysate as described in [26], and the glycosylase activity of RIPs with
DNA or RNA as substrates as described in [9], details being given in
the legends to the appropriate tables. The depurination of rat liver
ribosomes was performed either in the same conditions used for nu-
cleic acids, or at pH 7.8, with a reaction mixture described in the
legend to Fig. 1. Adenine released was measured as described [27].
Kinetic determinations were performed with the protocol described in
[28] with the aid of the program ‘hyper’ by J.S. Easterby or by non-
linear regression analysis (XLSTAT, Addinsoft, France).
3. Results
The e¡ect of type 2 RIPs on mammalian ribosomes was
¢rst evaluated in an indirect way, by assaying their inhibitory
activity on protein synthesis by a rabbit reticulocyte lysate. All
RIPs inhibited protein synthesis, although with very di¡erent
potency (Table 1). As is known, the activity of all toxic type 2
Fig. 1. Depurination of rat liver ribosomes by two toxic (b abrin a,
F volkensin) and a non-toxic (a RCA 120) RIPs. Reaction mixtures
contained, in a ¢nal volume of 200 Wl, 0.002 M Tris^HCl bu¡er,
0.02 M sucrose, 0.015 M KCl, 0.135 M NH4Cl, 0.001 M Mg-ace-
tate, 0.02 M NH4-acetate, the appropriate amount of abrin (a) or
RCA 120 and 9 pmol of ribosomes. Incubation was at 30‡C for 40
min. Maximum rate was 22.3 and 0.093 pmol/min/pmol RIP for
abrin a and RCA, respectively.
Table 1
E¡ect of type 2 RIPs on protein synthesis by a rabbit reticulocyte
lysate
RIP Inhibition of protein synthesis (IC50, nM)
Native protein Reduced protein
Toxic proteins
Abrin a 88 0.5
Ricin 84 0.1
Mistletoe lectin I 43.3 3.5
Modeccin 45 2.3
Volkensin 84 0.37
Non-toxic proteins
RCA 120 Inactivea 0.05
Cinnamomin 30.5 7.4
Ebulin l Inactivea 0.15
Ebulin r1 59.6 0.34
Ebulin r2 0.6 1.14
Nigrin b s 100 0.1
SNA I 2.7 1.65
SNLRP 6.03 5.74
IRA b 2.9 3.6
IRA r 5.8 4.7
Reaction mixtures contained, in a ¢nal volume of of 62.5 Wl : 10
mM Tris^HCl bu¡er, pH 7.4, 100 mM ammonium acetate, 2 mM
magnesium acetate, 1 mM ATP, 0.2 mM GTP, 15 mM phosphoc-
reatine, 3 Wg of creatine kinase, 0.05 mM amino acids (minus leu-
cine), 89 nCi of L-[14C]leucine, scalar concentrations of RIP and 25
Wl of rabbit reticulocyte lysate. Incubation was at 28‡C for 5 min.
The reaction was arrested with 1 ml of 0.1 M KOH, and two drops
of H2O2 and 1 ml of 10% (w/v) of trichloroacetic acid were added.
Precipitated proteins were collected on glass ¢ber discs and the ra-
dioactivity incorporated into protein was measured.
aAt 100 nM concentration.
Table 2
Glycosylase activity of RIPs on herring sperm DNA and on rRNA
RIP Glycosylase activity (pmol adenine released/pmol RIP/min)
Substrate hsDNA rRNA
Unreduced lectin Reduced lectin Unreduced lectin
Toxic proteins
Abrin a 0.67 0.03 0.63
Ricin 1.52 1.38 0.57
Mistletoe lectin I 0.28 0.38 0.24
Modeccin 0.03 0 0.22
Volkensin 0.15 0.04 0
Non-toxic proteins
RCA 120 0.25 0.33 0.02
Cinnamomin 0.18 0.18 0.05
Ebulin l 1.38 0.18 0.06
Ebulin r1 1.51 0.44 0.13
Ebulin r2 0.94 0.07 0.05
Nigrin b 1.10 0.30 0.06
SNA I 0.05 0.04 0.06
SNLRP 0.34 0.14 0.04
IRA b 1.34 0.23 0.21
IRA r 1.79 0.51 0.23
Reaction mixtures contained, in a ¢nal volume of 50 Wl : 50 mM Na-acetate bu¡er, pH 4.0, 100 mM KCl, 10 Wg of hsDNA or rRNA and
3 pmol of RIP.
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RIPs in the native status was relatively low, and was enhanced
when they were reduced to separate their A and B chains. In
the same system, the activity of ¢ve non-toxic RIPs (RCA
120, cinnamomin, ebulin l1, ebulin r1, nigrin b) was similarly
low, and again was enhanced by reduction, whereas the other
non-toxic lectins (ebulin r2, SNA I, SNLRP, IRA b and IRA
r) already had a high activity in the native state, which was
not enhanced or even slightly hampered (ebulin r2, IRA b and
IRA r) by reduction.
The glycosylase activity was assayed on nucleic acids as
substrates at pH 4.0, optimal for RIP activity on these sub-
strates [29,30]. All RIPs were active on hsDNA, again within
a wide range. RCA 120 was the most active, followed, in
descending order, by ebulin r, ricin and abrin, whilst volken-
sin was the least active (Table 2). The activity was almost
always decreased when the lectins were reduced. The glycosy-
lase activity was tested also on rRNA and in all cases was
lower than on hsDNA (Table 2). Under the same experimen-
tal conditions, the activity of RIPs on rat liver ribosomes was
very low if not absent (Table 3), in contrast to numerous
previous observations performed at pH 7, con¢rmed with
representative RIPs (Fig. 1).
The kinetics of the glycosylase activity of ricin on hsDNA
was studied, and the following values were obtained: Km 152
WM, Vmax 31 Wmol/min, and Kcat 9.3 min31.
4. Discussion
The ¢rst consideration emerging from the present results is
that type 2 RIPs di¡er considerably from each other in their
enzymatic activities on various substrates. Thus the inhibitory
activity on cell-free protein synthesis, an expression of damage
to mammalian ribosomes, varies by more than two orders of
magnitude among both toxic and non-toxic lectins, the latter
being, on average, not less active than the toxic ones.
All lectins had glycosylase activity on hsDNA, but generally
much less on rRNA. Again, there was no correlation with the
activity on a functioning complete translation system (a rabbit
reticulocyte lysate).
To be fully active on the reticulocyte lysate system, i.e. on
ribosomes, most lectins must be reduced. However, two of
them, ebulin r2 and IRS b, in the native state had a high
activity, which was not increased by reduction. This suggests
that when RIPs are in the native state, in most of them the
active site does not have access to the ribosome substrate,
because of steric hindrance by the B chain. It is noteworthy
that the activity of all RIPs on DNA (i) in no case was in-
creased more than 1.5-fold, and (ii) in most cases was actually
signi¢cantly decreased by reduction. This indicates that the
preparation of DNA utilized in the present experiments, being
smaller (median length 1 kb) than ribosomes, has access to the
active site of the native proteins. A ricin holotoxin containing
a non-reducible covalent linker between the subunits was in-
active on ribosomes, and still remained almost as toxic to
mammalian cells as the native ricin [31]. This suggests that
within the cells either the modi¢ed molecule undergoes some
change, or the toxin could hit targets other than ribosomes.
The higher activity of RIPs at acidic than at basic pH, on
both DNA and RNA [29,30], could be explained assuming
that the acidic pH favors a more unlocked and rigid structure
sustained by the electric repulsion of the negative polyphos-
phate backbone, which enables an easier accessibility of nu-
cleic acids to RIPs. At basic pH the negative charges are
neutralized, hence allowing a more compact and thus less
accessible structure. Ribosomes are not depurinated under
the optimal conditions for depurination of nucleic acids.
These di¡erences suggest that RIPs may act on di¡erent sub-
strates depending upon the conditions in various cell compart-
ments or organelles.
The activity on various substrates is not related to the tox-
icity of type 2 RIPs to cells and animals. The reason(s) for the
di¡erent toxicity could be in the binding to cells, entry into
the cytoplasm, intracellular routing and degradation of the
proteins.
It should be recalled here that there are pronounced di¡er-
ences in sugar binding speci¢city between the B chains of type
2 RIP/lectins from elderberry, apparently depending on spe-
ci¢c amino acid substitutions in the respective carbohydrate
binding sites [32,33]. Basic nigrin b, a very active two-chain
RIP, does not display carbohydrate binding activity and
therefore has no toxicity on mice even at 40 mg/kg body
weight [34]. Also, from structural data, it has been argued
that ebulin l lacks the lipase active site of ricin and abrin,
which has been suggested to have a role in the toxicity of
ricin [35].
In a study on cell entry and intracellular fate of ricin and
nigrin, one of the less toxic RIPs, it was observed that nigrin
b, as compared with ricin, binds equally well to cells, but a
greater proportion of it goes to the lysosomes, where it is
degraded and expelled from cells [36]. Moreover, the low ly-
sine content may render the ricin A chain resistant to proteo-
lytic degradation [37].
In conclusion, the di¡erences in the cytotoxicity of RIPs
cannot be accounted for by their enzymatic activity. Presum-
ably di¡erences in their intracellular fate are important, on
which, however, comparative studies are still too scarce to
give su⁄cient information.
The di¡erences in the activity reported here, other proper-
ties of RIPs, and their di¡erent concentrations and localiza-
Table 3
Glycosylase activity of RIPs on rat liver ribosomes
RIP Glycosylase activity (pmol adenine released/
pmol enzyme/60 min)
Toxic proteins
Abrin a 0.024
Ricin 0.513
Mistletoe lectin I 0.035
Modeccin 0
Volkensin 0.008
Non-toxic proteins
RCA 120 0.083
Cinnamomin 0.014
Ebulin l 0.014
Ebulin r1 0.037
Ebulin r2 0.053
Nigrin b 0.023
SNA I 0
SNLRP
IRA b 0.109
IRA r 0.116
Reaction mixtures contained, in a ¢nal volume of 50 Wl : 50 mM
Na-acetate bu¡er, pH 4.0, 100 mM KCl, 5 pmol of rat liver ribo-
somes and 10 pmol of reduced RIP (5 pmol in the case of RCA
120, consisting of a dimer with two A chains). Adenine was deter-
mined as described [27].
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tion in plant tissues [1,4,38] all together point to possible
di¡erent biological roles played by type 1 and type 2 RIPs
in plants. Some type 1 RIPs accumulate in leaf senescence [39]
and in fruit ripening [38] whilst others are constitutive and do
not change with leaf life cycle [38]. In contrast, type 2 RIPs
almost disappeared in leaf senescence [40,41]. This clearly sup-
ports the belief that RIPs having a common enzymatic mech-
anism, namely adenine polynucleotide glycosylase, could be
e¡ector agents in di¡erent biological events of the plant.
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